--- title: OUVC | NEWS | news image: https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/ogp.png description: news | NEWS一覧ページです。大阪大学ベンチャーキャピタルは、大阪大学を始めとする国立大学の世界屈指の研究成果の社会創出を目指し、投資を通じて大学発の新産業の事業化及び事業支援を行います。 --- [![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/header_logo.svg)](https://www.ouvc.co.jp/en/?hsLang=en) - [ABOUT US](https://www.ouvc.co.jp/en/aboutus?hsLang=en) - [![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/headerBtn_company.jpg) COMPANY](https://www.ouvc.co.jp/en/aboutus?hsLang=en) - [![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/headerBtn_fund.jpg) FUND](https://www.ouvc.co.jp/en/fund?hsLang=en) - [NEWS](https://blog.ouvc.co.jp/en/) - [PORTFOLIO](https://www.ouvc.co.jp/en/portfolio?hsLang=en) - [MEMBER](https://www.ouvc.co.jp/en/member?hsLang=en) - [CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en) - [JP](https://blog.ouvc.co.jp/tag/news?hsLang=ja)/EN [JP](https://blog.ouvc.co.jp/tag/news?hsLang=ja)/EN [![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/header_logo.svg)](https://www.ouvc.co.jp/en/?hsLang=en) - [ABOUT US](https://www.ouvc.co.jp/en/aboutus?hsLang=en) - [COMPANY](https://www.ouvc.co.jp/en/aboutus?hsLang=en) - [FUND](https://www.ouvc.co.jp/en/fund?hsLang=en) - [NEWS](https://blog.ouvc.co.jp/?hsLang=en) - [PORTFOLIO](https://www.ouvc.co.jp/en/portfolio?hsLang=en) - [MEMBER](https://www.ouvc.co.jp/en/member?hsLang=en) - [CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en) ## NEWS [HOME](https://www.ouvc.co.jp//en?hsLang=en) NEWS - [ALL](https://blog.ouvc.co.jp/en/) - [news](https://blog.ouvc.co.jp/en/tag/news) - [investment](https://blog.ouvc.co.jp/en/tag/investment) - [event](https://blog.ouvc.co.jp/en/tag/event) YEAR ALL ALL 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 - ![noimage](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/noimage.png) 2026.10.01 Research Project Led by Gifu Pharmaceutical University’s Associate Professor Shinsuke Nakamura, Supported by OUVC, Selected for the Tongali GAP Fund Program STEP 2 - ![noimage](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/noimage.png) 2026.06.16 Venture Capitalist Shigehiro Asano Spoke at a Panel Discussion at the Life Science × Acceleration Forum 2026 - ![noimage](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/noimage.png) 2026.05.22 Three Technologies from The University of Osaka Selected for the 3rd KSAC GAP Fund — OUVC to Support Commercialization of a Sulfur Polymer, Heart Failure Drug, and Osteoporosis Treatment Device - ![noimage](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/noimage.png) 2026.05.13 Our Investment Director, Yuki Taga, Spoke at an Investor Session at SusHi Tech Tokyo 2026 - ![J-Pharma Co., Ltd. Listed on the Tokyo Stock Exchange Growth Market](https://blog.ouvc.co.jp/hubfs/J-Pharma_Blog.png) 2026.03.25 J-Pharma Co., Ltd. Listed on the Tokyo Stock Exchange Growth Market - ![ayumo Inc. and Revascular Bio Co., Ltd. Selected as ](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/230502_Blog.png) 2026.01.22 ayumo Inc. and Revascular Bio Co., Ltd. Selected as "J-Startup KANSAI" - ![noimage](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/noimage.png) 2025.12.25 Yuki Taga, Director of the Investment Department, Spoke at Ibex Japan’s Launch Event - ![noimage](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/noimage.png) 2025.11.21 Yuki Taga, Director of the Investment Department, Appointed as one of MEXT’s ‘Ambassadors for Entrepreneurship Promotion’ - ![noimage](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/noimage.png) 2025.11.18 Our Director of the Investment Department, Yuki Taga, delivered a keynote speech at the Link-J ‘CEO Roundtable’ - ![We sincerely congratulate Professor Shimon Sakaguchi of The University of Osaka on winning the Nobel Prize in Physiology or Medicine](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/230502_Blog.png) 2025.10.07 We sincerely congratulate Professor Shimon Sakaguchi of The University of Osaka on winning the Nobel Prize in Physiology or Medicine - ![OUVC and Antler Ibex Launch 'Ibex Venture Studio' to Drive Global Expansion of Kansai-Based Deep Tech Startups](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_pictures/250723_Blog.jpg) 2025.07.23 OUVC and Antler Ibex Launch 'Ibex Venture Studio' to Drive Global Expansion of Kansai-Based Deep Tech Startups - ![Notice Regarding Change of Representative Director and Additional Appointment to the Board](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/250611_Blog.png) 2025.06.11 Notice Regarding Change of Representative Director and Additional Appointment to the Board - ![noimage](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/noimage.png) 2025.06.06 OUVC Was Selected for NEDO's Management Personnel Matching Program - ![OUVC Sold Shares of AI Samurai Inc.](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/AISamurai_Blog.png) 2025.06.03 OUVC Sold Shares of AI Samurai Inc. - ![Thinker Inc. Has Launched a New Robot, ](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/Thinker_Blog_1.png) 2025.02.05 Thinker Inc. Has Launched a New Robot, "Thinker Model A" - ![Professor Emeritus Satoshi Kawata of The University of Osaka Was Selected as a Person of Cultural Merit](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/230502_Blog.png) 2024.10.30 Professor Emeritus Satoshi Kawata of The University of Osaka Was Selected as a Person of Cultural Merit - ![Thinker Co., Ltd. Won the JEITA Venture Awards](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/210329_Blog.png) 2024.03.29 Thinker Co., Ltd. Won the JEITA Venture Awards - ![OUVC Sold Shares of Nanophoton Corporation](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/%E3%83%8A%E3%83%8E%E3%83%95%E3%82%A9%E3%83%88%E3%83%B3_Blog.png) 2024.02.08 OUVC Sold Shares of Nanophoton Corporation - ![Periotherapia Co.,Ltd. Was Selected for AMED's Strengthening Program for Pharmaceutical Startup Ecosystem Initiative](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/%E3%83%9A%E3%83%AA%E3%82%AA%E3%82%BB%E3%83%A9%E3%83%94%E3%82%A2_Blog.png) 2023.12.06 Periotherapia Co.,Ltd. Was Selected for AMED's Strengthening Program for Pharmaceutical Startup Ecosystem Initiative - ![Thinker Co., Ltd. and Immunorock Co., Ltd. Were Selected as ](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/230502_Blog.png) 2023.09.27 Thinker Co., Ltd. and Immunorock Co., Ltd. Were Selected as "J-Startup KANSAI" - ![OUVC Has Launched the Entrepreneur in Residence Program](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/230921_Blog.png) 2023.09.21 OUVC Has Launched the Entrepreneur in Residence Program - ![Ai-Brain Science Co., Ltd. Was Selected in the Forbes Asia 100 to Watch 2023](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/Ai-BrainScience_Blog.png) 2023.09.04 Ai-Brain Science Co., Ltd. Was Selected in the Forbes Asia 100 to Watch 2023 - ![Ai-Brain Science Co., Ltd. Won “The Japan Medical Research and Development Start-up Encouragement Prize” at the Japan Medical Research and Development Grand Prize](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/Ai-BrainScience_Blog.png) 2023.08.28 Ai-Brain Science Co., Ltd. Won “The Japan Medical Research and Development Start-up Encouragement Prize” at the Japan Medical Research and Development Grand Prize - ![OUVC Sold Shares of KOTAI Biotechnologies Co., Ltd.](https://blog.ouvc.co.jp/hubfs/Imported_Blog_Media/Blog_%E3%82%A2%E3%82%A4%E3%82%AD%E3%83%A3%E3%83%83%E3%83%81%E7%94%BB%E5%83%8F/KOTAI_Blog.png) 2023.07.31 OUVC Sold Shares of KOTAI Biotechnologies Co., Ltd. [1](https://blog.ouvc.co.jp/en/tag/news/page/1) [2](https://blog.ouvc.co.jp/en/tag/news/page/2) [![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/footer__logo.svg)](https://www.ouvc.co.jp/en/?hsLang=en) OSAKA University Venture Capital 3F, TechnoAlliance Complex, 2-8 Yamadaoka, Suita City Osaka 565-0871 ### CONTACT Please feel free to contact us for a consultation. [CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en) [ABOUT US](https://www.ouvc.co.jp/en/aboutus?hsLang=en) [COMPANY](https://www.ouvc.co.jp/en/aboutus?hsLang=en) [FUND](https://www.ouvc.co.jp/en/fund?hsLang=en) [PORTFOLIO](https://www.ouvc.co.jp/en/portfolio?hsLang=en) [MEMBER](https://www.ouvc.co.jp/en/member?hsLang=en) [CONTACT](https://www.ouvc.co.jp/en/contact?hsLang=en) [THE UNIVERSITY OF OSAKA](https://www.osaka-u.ac.jp/ja) [Co-Creation Bureau, the University of Osaka](https://www.ccb.osaka-u.ac.jp) [FUND COORDINATION](https://www.ouvc.co.jp/en/link?hsLang=en) Copyright 2023 OSAKA University Venture Capital Co., Ltd. All Rights Reserved. [CORPORATE POLICIES](https://connect.ouvc.co.jp/en/corporate-policies?hsLang=en) ![](https://blog.ouvc.co.jp/hubfs/raw_assets/public/ouvc/img/common/arrow_top.svg)